3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Sarcoma, Ewing
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Jaundice
1
Endocrine Gland Neoplasms
1
Interventions
Gemcitabine
3
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
napabucasin
1
ganitumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Endocrine Gland Neoplasms
×
ganitumab
×
Clear all
NCT01231347
2024-07-16
GAMMA
NantCell, Inc.
Phase 3
Completed
800 enrolled
11 charts